Financial Year |
March 31 2023 |
Monetary Funds |
936,202,310.31 |
Held-for-trading Financial Assets |
167,731,279.02 |
Notes Receivable |
63,484,870.17 |
Accounts Receivable |
474,262,843.28 |
Advances to Suppliers |
308,156,806.26 |
Other Receivables |
10,359,819.94 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,137,106,806.26 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
41,427,063.26 |
Total Current Assets |
4,229,226,811.88 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
58,482,027.62 |
Investment Properties |
-- |
Fixed Assetes |
885,088,873.89 |
Under-construction Projects |
81,677,625.77 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
209,860,742.48 |
R&D expenses |
-- |
Goodwill |
1,042,371,964.24 |
Long-Term Deferred and Prepaid Expenses |
5,987,171.97 |
Deferred Income Tax Assets |
37,478,674.68 |
Other Non-Current Assets |
58,964,029.56 |
Sub-Total of Non-Current Assets |
2,423,951,329.07 |
Total Assets |
6,653,178,140.95 |
Short-Term Loans |
666,435,702.25 |
Trading Financial liabilities |
-- |
Notes Payable |
225,570,471.20 |
Accounts Payable |
846,974,474.31 |
Accounts Received In Advance |
7,262,380.35 |
Employee Compensation Payable |
26,808,449.42 |
Taxes Payable |
28,767,039.61 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
39,127,703.14 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
13,828,739.19 |
Other Current Liabilities |
13,809,940.72 |
Sub-Total of Current Liabilities |
1,989,783,209.67 |
Long-term Loans |
200,100,000.00 |
Bonds Payable |
386,885,999.79 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
29,069,241.46 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
655,769,287.70 |
Total Liabilities |
2,645,552,497.37 |
Paid-In Capital(Or Share Stock) |
581,951,198.00 |
Capital Surplus |
1,636,047,532.43 |
Surplus Reserve |
111,418,743.11 |
LESS:Treasury Stock |
54,688,745.70 |
Undistributed Profits |
1,518,917,775.99 |
Minority Stockholder's Interest |
90,221,549.48 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,917,404,094.10 |
Owner's Equity(Stockholder's Equity) |
4,007,625,643.58 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
6,653,178,140.95 |